Product Information
MINOCYCLINE 100 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3425 per EA under NDC 65862021150. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Mar 11, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Minocycline Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862021150
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065470FDA Approved
3/11/2008
TE Code
AB
On Market Since
3/11/2008
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE 100 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 42.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3425 per EA |
|---|---|
| All-time high | $0.5239 (Jul 12, 2017) |
| All-time low | $0.2345 (Oct 22, 2014) |
| 52-week high | $0.3688 |
| 52-week low | $0.3392 |
| Median price | $0.3670 |
| Average price | $0.3684 |
| Largest weekly change | +57.3% (Dec 17, 2014) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Minocycline Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tetracycline-class Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MINOCYCLINE 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE 100 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.3425 per EA (NDC 65862021150), effective Sep 30, 2026.
How has the price of MINOCYCLINE 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE 100 MG CAPSULE has risen 42.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE 100 MG CAPSULE?
Since Nov 28, 2013, the NADAC for MINOCYCLINE 100 MG CAPSULE has ranged from a low of $0.2345 (Oct 22, 2014) to a high of $0.5239 (Jul 12, 2017), with a median of $0.3670 per EA.
Are there cheaper alternatives to MINOCYCLINE 100 MG CAPSULE?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MINOCYCLINE 100 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures MINOCYCLINE 100 MG CAPSULE?
MINOCYCLINE 100 MG CAPSULE (NDC 65862021150) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.